MINING.COM

The Precision Peptide Company Appoints Certified Peptide Therapist and Integrative Health Coach Diane Stafrace to Advisory Board

Friday, July 3, 2026 4:00 AM PDT

(via TheNewswire)

Key Highlights:

Diane Stafrace, a Vancouver-based Certified Peptide Therapist, Certified Integrative Health Coach, and NASM-certified Personal Trainer, has joined the Advisory Board of The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF).

Stafrace brings hands-on experience in the peptide industry and a strong presence within the North American peptide wellness community, offering the Company direct insight into the space it operates in.

Prior to her wellness career, Stafrace spent five years as a medical representative, giving her a strong foundation in the OTC and broader healthcare sector.

Stafrace's credentials include certification in Peptide Therapy from Empowered Academy USA, Certified Integrative Health Coach from the Institute for Integrative Nutrition (IIN), Certified Personal Trainer and Behaviour Change Specialist from the National Academy of Sports Medicine (NASM), and a B.Sc. in Mass Communications from the University of Malta.

Stafrace is the founder of Get Set by Diane, an integrative wellness practice offering personalized peptide protocols, GLP-1 support, and lifestyle coaching to clients focused on performance, recovery, and longevity.

A respected authority in integrative peptide wellness, Stafrace is known for guiding clients toward lasting, meaningful results through a personalized, whole-person approach to health.

VANCOUVER, BRITISH COLUMBIA – TheNewswire - July 3, 2026 – The Precision Peptide Company Inc. (CSE: BPC) (OTCQB: PNGAF) ("Precision Peptide" or the "Company") is pleased to announce the appointment of Diane Stafrace to its Advisory Board. Stafrace is a Certified Peptide Therapist and Integrative Health Coach based in Vancouver, British Columbia, whose practice sits at the intersection of peptide science, integrative nutrition, and behavior change.

About Diane Stafrace

Stafrace is the founder of Get Set by Diane, a Vancouver-based integrative health practice where she designs personalized peptide protocols and wellness programs for clients focused on performance, recovery, longevity, and overall well-being. Her work spans peptide therapy consulting, GLP-1 support, personalized nutrition, and behavior change coaching, with a core philosophy centered on addressing root causes rather than symptoms and building wellness habits that last.

Her credentials include Certification in Peptide Therapy from Empowered Academy USA, Certified Integrative Health Coach from the Institute for Integrative Nutrition (IIN), Certified Personal Trainer and Behaviour Change Specialist from the National Academy of Sports Medicine (NASM), and a B.Sc. in Mass Communications from the University of Malta. Earlier in her career, she spent five years as a medical representative, building a foundation in the OTC and broader healthcare sector that continues to inform her integrative approach today.

Known for a personalized, whole-person approach to health, Stafrace works closely with clients to deliver lasting, meaningful results across performance, recovery, and longevity. Her perspective is expected to support Precision Peptide’s continued consumer education efforts as the market for peptide-based wellness solutions expands.

“Diane brings something our Advisory Board genuinely needed, a practitioner’s view of how peptides perform in real people’s lives. The wellness categories she works in every day, including recovery, performance, immunity, and longevity, map directly onto the Amino Innovations portfolio. As demand for peptide-based wellness products accelerates, Diane’s perspective will be invaluable as we continue to scale.”

— Pratap Sandhu, CEO, The Precision Peptide Company

“Peptides are one of those ‘how did we not know about this sooner’ tools in wellness, and the demand from clients right now is real. What drew me to Precision Peptide is that they’re doing this the smart way, with real science, real testing, and advanced transdermal and oral delivery systems engineered for optimal absorption. That kind of innovation is exactly what this space has been waiting for. I’m genuinely thrilled to be joining the Advisory Board and excited for what’s ahead.”

— Diane Stafrace, Certified Peptide Therapist and Integrative Health Coach

About The Precision Peptide Company

The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the Company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America.

For more information, visit: www.precisionpeptidecompany.com

Company Contact

Pratap Sandhu, Chief Executive Officer

pratap@precisionpeptidecompany.com +1 (604) 765-8069

Cautionary Note Regarding Forward-Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the anticipated benefits of Diane Stafrace’s appointment to the Company’s Advisory Board; the expected contribution of her experience to the Company’s advisory, consumer education, product positioning, and growth initiatives; the Company’s plans to develop and scale its peptide-based wellness platform; and expected market demand for peptide-based wellness products.

Forward-looking information is based on management’s current expectations, assumptions, and beliefs, including assumptions regarding the relevance of Ms. Stafrace’s experience to the Company’s business, continued consumer interest in peptide-based wellness products, the Company’s ability to develop, manufacture, market, and distribute its products in compliance with applicable laws, and the availability of suppliers, manufacturers, distribution channels, personnel, advisors, and capital.

Forward-looking information is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including risks related to the Company’s early-stage business, execution of its business plan, product development, formulation, testing, manufacturing, labelling, marketing, regulatory compliance, market acceptance, competition, supply chain matters, financing, reliance on third parties and key personnel, and changes in laws, regulations, enforcement priorities, or consumer perception relating to peptide-based, wellness, health, GLP-1-related, or consumer health products.

Readers are cautioned not to place undue reliance on forward-looking information. The forward-looking information in this news release is made as of the date hereof, and the Company undertakes no obligation to update or revise such information except as required by applicable securities laws.